home.aspx
 
. https://pharmaceutical.report/Resources/Whitepapers/9d8a8e46-5aee-46c5-93c8-89cc7fb0eae0_Comparative Tolerability Whitepaper_FINAL.pdf
whitepaper
SHARESHARESHARE
BROADENING THE DEFINITION OF TOLERABILITY IN CANCER CLINICAL TRIALS TO BETTER MEASURE THE PATIENT EXPERIENCE
Robust safety and tolerability data are essential in cancer therapeutic studies, and some trials are specifically designed with a key objective of demonstrating improved safety and tolerability. The development of a clinical trial framework and data elements to demonstrate comparative safety and tolerability requires a suite of endpoints and approaches to enable meaningful interpretation of results for regulatory and clinical decision-making. DOWNLOAD